BioE Selected as a 2005 Tekne Award Finalist; Annual Award Program Honors Companies and Individuals Who Have Shown Superior Technology Innovation and Leadership in Minnesota.

ST. PAUL, Minn. -- BioE(R), Inc., a biomedical company providing enabling non-embryonic, human stem cells, announced today the Minnesota High Tech Association (MHTA) and Minnesota Technology, Inc. (MTI), in partnership with Medical Alley/MNBio, selected it as a 2005 Tekne Award finalist in the emerging biotechnology company category. The Tekne Awards, now in their sixth year, honor companies and individuals who have shown superior technology innovation and leadership in Minnesota. E[acute accent]"We are very pleased to be named a finalist for one of Minnesota's most prestigious business and technology awards," said Michael Haider, president and chief executive officer for BioE. "This recognition validates the tremendous effort we have made to pioneer a new category of stem cell solutions with our cutting-edge Multi-Lineage Progenitor Cell(TM) (MLPC(TM)). These cells will be used to help develop new clinical therapeutics and enhance drug discovery and screening processes, eventually leading to improved patient outcomes. As a Tekne finalist and emerging leader in the business community, BioE is proud to represent the state of Minnesota as it continues to establish itself as one of the nation's premier centers for technological innovation, especially in the medical technology and biotechnology industries." E[acute accent]BioE was selected as a Tekne finalist based on its ability to exhibit: a meaningful impact on the growth, success and sustainability of Minnesota's technology-based economy; a vision in helping to shape the future of technology; and excellence, integrity and persistence in pursuing that vision. E[acute accent]The 2005 Tekne Awards will be presented on Thurs., Nov. 10, 2005 at the Minneapolis Convention Center. For more information about the Tekne Awards or the ceremony, visit www.tekneawards.org.

E[acute accent]About BioE

E[acute accent]Headquartered in St. Paul, Minn., BioE is a biomedical company providing enabling non-embryonic, human stem cells. Privately owned and founded in 1993, the company's Cell Biologics -- including BioE's novel Multi-Lineage Progenitor Cell (MLPC) -- provide a non-controversial therapeutic research alternative to embryonic stem cells and less-plastic adult stem cells, and significantly enhance high-throughput drug discovery and screening processes. For more information about BioE, please visit www.bioe.com or call [phone].

E[acute accent]About MTI

E[acute accent]Minnesota Technology, Inc. (MTI) is a nonprofit, 501(c) (3) organization whose mission is to help its business customers gain competitive advantages, support their growth, and contribute to Minnesota's economic vitality. It fulfills this work through a statewide staff of expert professionals who have tested expertise across a wide variety of business, technology, manufacturing, engineering, publishing and research disciplines. In the last three years, MTI has helped nearly 2,000 Minnesota companies and made a significant economic impact. It helped create and retain over 2,500 jobs, saved its clients more than $70 million, and helped generate $80 million in new technology investments. For more information visit http://www.minnesotatechnology.org.

E[acute accent]About MHTA

E[acute accent]The Minnesota High Tech Association (MHTA) accelerates the growth, success and sustainability of Minnesota's technology-based economy through public policy advocacy, member collaboration and education, and community outreach. MHTA is the only membership organization that represents Minnesota's entire technology-based economy. MHTA members include organizations of every size -- involved in virtually every aspect of technology creation, production, application and education in Minnesota. MHTA works in partnership with AeA, which represents Minnesota's technology organizations nationally. More information on the MHTA can be found at http://www.mhta.org.